Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and irinotecan in carcinoma of unknown primary has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Carcinoma of Unknown Primary | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04